pCAD-POAF 3 Year Follow-up
Launched by CHINA NATIONAL CENTER FOR CARDIOVASCULAR DISEASES ·
Trial Information
Current as of September 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is a follow-up study looking at patients who previously took part in the pCAD-POAF trial, which involved people with coronary artery disease and atrial fibrillation (an irregular heart rhythm). The study will check on these patients three years after their heart surgery to see how their heart rhythm has been doing. Specifically, researchers want to measure how much atrial fibrillation (AF) the patients experience over a three-day heart monitor test and whether they remain free of AF without needing medications or other treatments. They will also track serious health events like stroke, heart attacks, or hospital visits, as well as overall heart health, heart rates, and quality of life.
People who took part in the original pCAD-POAF trial are eligible to join this follow-up. Participants can expect to have their heart rhythm monitored for several days using a portable device and answer questions about their health and daily life. This study is not yet recruiting new participants, and it aims to learn more about the long-term effects of heart surgery on rhythm and overall wellbeing, which could help improve future care for patients with heart artery disease and atrial fibrillation.
Gender
ALL
Eligibility criteria
About China National Center For Cardiovascular Diseases
The China National Center for Cardiovascular Diseases (NCCD) is a leading research and clinical trial sponsor dedicated to advancing cardiovascular health in China and globally. As a prominent institution, NCCD focuses on innovative research, clinical management, and education in cardiovascular medicine. The center plays a crucial role in conducting rigorous clinical trials aimed at developing new therapies and improving patient outcomes for cardiovascular diseases. Through collaboration with national and international partners, NCCD is committed to enhancing the understanding of cardiovascular conditions and translating research findings into practical applications for improved healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Wei Feng, MD
Principal Investigator
Chinese Academy of Medical Sciences, Fuwai Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported